Training Africans to Lead and Execute Neurological Trials & Studies (TALENTS)

培训非洲人领导和执行神经学试验

基本信息

项目摘要

PROJECT SUMMARY / ABSTRACT Africa faces a growing burden of non-communicable diseases as the fastest growing cause of morbidity and mortality, many of which are neurological disorders. Clinical studies are the foundation advancements in medicine allowing scientists to test the efficacy and safety of a drug, therapy or strategy; and clinical neuroscience research holds great promise to help mitigate the toll of neurological disease. However, the studies that lead to discovery of causal /risk factors & drugs/interventions rarely emanate from African populations, which bear a major brunt of neurological diseases. With the rise of precision medicine utilizing tailored interventions, lack of race-ethnic diversity in generating evidence-based treatments can be a challenge if people of African ancestry are to truly benefit from these targeted therapies. One way to bolster the limited pool of researchers in Africa conducting neurological research and trials is to expose select individuals to coordinated education, training, mentoring, & networking opportunities, thereby raising their odds of becoming successful clinical researchers, thus creating a cadre of people on the continent making academic contributions to the overall field of neurological diseases, including those conditions endemic to Africa. The goal of the Training Africans to Lead and Execute Neurological Trials & Studies (TALENTS) program, is to build sustainable neurological research capacity in Africa through partnerships between US and African organizations. Six scholars will be accepted into the program each year and exposed to educational, mentoring, & networking activities. TALENTS Specific Aims are: 1) To select & retain 24 promising multidisciplinary scholars from a cross-national pool) committed to careers in neurological research; 2) To increase scholars' scientific knowledge, professional skills, motivation, & credentials, in neurological research (Certificate Program, Master’s degree in Clinical Research, Think Tank Sessions, and Scientific Conference events); 3) To enhance mentoring benefits and networking opportunities for Scholars (congruent one-on-one mentoring approach and online networking activities); 4) By end of the grant period to create an independent Master’s degree in Neurological Research at the University of Ibadan in Nigeria, with several member of the faculty being recent TALENTS trainees; 5) To evaluate the effectiveness of the Program. We anticipate that TALENTS will establish a sustainable network of individuals with expertise in neurological research poised to assume leadership and academic faculty roles in Africa, and able to mentor successive generations of locally well-trained and successful neurological researchers in the region.
项目摘要/摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRUCE OVBIAGELE其他文献

BRUCE OVBIAGELE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRUCE OVBIAGELE', 18)}}的其他基金

Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment II Study
通过在常规治疗中添加抗动脉粥样硬化药物来最大限度地减少中风 II 研究
  • 批准号:
    10686912
  • 财政年份:
    2022
  • 资助金额:
    $ 24.64万
  • 项目类别:
Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment II Study
通过在常规治疗中添加抗动脉粥样硬化药物来最大限度地减少中风 II 研究
  • 批准号:
    10539167
  • 财政年份:
    2022
  • 资助金额:
    $ 24.64万
  • 项目类别:
Health Equity & Actionable Disparities in Stroke: Understanding & Problem-solving (HEADS-UP) Symposium
健康公平
  • 批准号:
    10378532
  • 财政年份:
    2021
  • 资助金额:
    $ 24.64万
  • 项目类别:
Health Equity & Actionable Disparities in Stroke: Understanding & Problem-solving (HEADS-UP) Symposium
健康公平
  • 批准号:
    10583507
  • 财政年份:
    2021
  • 资助金额:
    $ 24.64万
  • 项目类别:
Training Africans to Lead and Execute Neurological Trials & Studies (TALENTS)
培训非洲人领导和执行神经学试验
  • 批准号:
    10483218
  • 财政年份:
    2021
  • 资助金额:
    $ 24.64万
  • 项目类别:
Phone-based Interventions under Nurse Guidance after Stroke II (PINGS II)
中风后在护士指导下进行的电话干预 II (PINGS II)
  • 批准号:
    10405058
  • 财政年份:
    2020
  • 资助金额:
    $ 24.64万
  • 项目类别:
Sub-Saharan Africa Conference on Stroke (SSACS) Conference
撒哈拉以南非洲卒中会议 (SSACS) 会议
  • 批准号:
    10066812
  • 财政年份:
    2020
  • 资助金额:
    $ 24.64万
  • 项目类别:
African Rigorous Innovative Stroke Epidemiological Surveillance (ARISES)
非洲严格创新中风流行病学监测 (ARISES)
  • 批准号:
    10411897
  • 财政年份:
    2020
  • 资助金额:
    $ 24.64万
  • 项目类别:
African Rigorous Innovative Stroke Epidemiological Surveillance (ARISES)
非洲严格创新中风流行病学监测 (ARISES)
  • 批准号:
    10579303
  • 财政年份:
    2020
  • 资助金额:
    $ 24.64万
  • 项目类别:
Phone-based Interventions under Nurse Guidance after Stroke II (PINGS II)
中风后在护士指导下进行的电话干预 II (PINGS II)
  • 批准号:
    10602449
  • 财政年份:
    2020
  • 资助金额:
    $ 24.64万
  • 项目类别:

相似海外基金

Optimizing the vaginal microbiome In African, Caribbean and other Black women from Toronto, Canada: defining clinical endpoints and community priorities
优化来自加拿大多伦多的非洲、加勒比和其他黑人女性的阴道微生物组:确定临床终点和社区优先事项
  • 批准号:
    494152
  • 财政年份:
    2023
  • 资助金额:
    $ 24.64万
  • 项目类别:
    Operating Grants
Clinical Trial of the Fit Families Multicomponent Obesity Intervention for African American Adolescents and Their Caregivers: Next Step from the ORBIT Initiative
针对非裔美国青少年及其照顾者的 Fit Families 多成分肥胖干预的临床试验:ORBIT Initiative 的下一步
  • 批准号:
    10666990
  • 财政年份:
    2022
  • 资助金额:
    $ 24.64万
  • 项目类别:
Exploring APOL1 genetic risk and family perspectives on clinical genetic testing in children of African ancestry with nephrotic syndrome in Ontario
探讨安大略省非洲血统肾病综合征儿童的 APOL1 遗传风险和家庭视角对临床基因检测的影响
  • 批准号:
    486524
  • 财政年份:
    2022
  • 资助金额:
    $ 24.64万
  • 项目类别:
    Studentship Programs
Sickle Pan-African Research Consortium (SPARCO) Uganda: Strengthening Capacity for Clinical Care, Research and Training in Sickle Cell Disease - SCRT Project.
镰状细胞泛非研究联盟 (SPARCO) 乌干达:加强镰状细胞病临床护理、研究和培训的能力 - SCRT 项目。
  • 批准号:
    10414949
  • 财政年份:
    2021
  • 资助金额:
    $ 24.64万
  • 项目类别:
NorthStar Node of the Clinical Trials Network: Engaging African American Faith-Based Leaders in a Substance Use Learning Collaborative (LC)
临床试验网络的北极星节点:让非洲裔美国信仰领袖参与药物使用学习协作 (LC)
  • 批准号:
    10441668
  • 财政年份:
    2021
  • 资助金额:
    $ 24.64万
  • 项目类别:
A clinical prediction rule for identifying South African colorectal cancer patients who will fail to engage in oncology care
用于识别无法参与肿瘤护理的南非结直肠癌患者的临床预测规则
  • 批准号:
    10480832
  • 财政年份:
    2021
  • 资助金额:
    $ 24.64万
  • 项目类别:
A clinical prediction rule for identifying South African colorectal cancer patients who will fail to engage in oncology care
用于识别无法参与肿瘤护理的南非结直肠癌患者的临床预测规则
  • 批准号:
    10689780
  • 财政年份:
    2021
  • 资助金额:
    $ 24.64万
  • 项目类别:
Sickle Pan-African Research Consortium (SPARCO) Uganda: Strengthening Capacity for Clinical Care, Research and Training in Sickle Cell Disease - SCRT Project.
镰状细胞泛非研究联盟 (SPARCO) 乌干达:加强镰状细胞病临床护理、研究和培训的能力 - SCRT 项目。
  • 批准号:
    10182610
  • 财政年份:
    2021
  • 资助金额:
    $ 24.64万
  • 项目类别:
A clinical prediction rule for identifying South African colorectal cancer patients who will fail to engage in oncology care
用于识别无法参与肿瘤护理的南非结直肠癌患者的临床预测规则
  • 批准号:
    10295819
  • 财政年份:
    2021
  • 资助金额:
    $ 24.64万
  • 项目类别:
Sickle Pan-African Research Consortium (SPARCO) Uganda: Strengthening Capacity for Clinical Care, Research and Training in Sickle Cell Disease - SCRT Project.
镰状细胞泛非研究联盟 (SPARCO) 乌干达:加强镰状细胞病临床护理、研究和培训的能力 - SCRT 项目。
  • 批准号:
    10634627
  • 财政年份:
    2021
  • 资助金额:
    $ 24.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了